Linked Life Data

15152647

Source:http://linkedlifedata.com/resource/pubmed/id/15152647

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2004-5-20
pubmed:abstractText
Total artificial heart technology as a potential clinical therapy raises the issue of elective device inactivation in both futile and non-futile situations. This article explores elective device inactivation in non-futile situations. In reply to such requests for inactivation, the medical team should reflect on the individual's decision-making capacity, the clinical appropriateness of the therapy, and the setting of the request (clinical research vs. clinical practice). A decision-making flowchart is presented as a guide for managing inactivation requests. In the research setting, current U.S. federal regulations are murky as to the matter of study withdrawal made by participants who lack decision-making capacity. This compared with clear legal and ethical approaches in the non-research setting (clinical practice).
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
E
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0748-1187
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
HSR
pubmed:authorsComplete
Y
pubmed:pagination
423-33
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Elective inactivation of total artificial heart technology in non-futile situations: inpatients, outpatients and research participants.
pubmed:affiliation
Department of Bioethics, The Cleveland Clinic Foundation, Cleveland, Ohio, USA. bioethics@go.com
pubmed:publicationType
Journal Article